Digital
On AI and computational support of biochemistry, with Alan R...
Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Digital
Regulators open the AI floodgates in life sciences
In 2026, biopharma will move from proving AI works to proving it can be trusted at scale.
Digital
Balancing global consistency and local nuance: EVERSANA on A...
The conversation around global brand launches is evolving rapidly – and EVERSANA and its agency team at EVERSANA INTOUCH’s leadership is at the centre
News
Chai raises $130m for AI drug discovery platform
AI specialist Chai Discovery has said it is sitting on a valuation of around $1.3 billion, after raising $130 million in a Series B financing.
News
UK teams up with Singapore on healthtech regulation
A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
Debates
News
Press Releases
Editor's Picks
Editor's Picks
